Immatics
potential for large patient populations across multiple solid cancers so | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
10 of 75
Related slides by other companies
AstraZeneca
Results
November 2024
armored multiple cancers ess | AstraZeneca
Exscientia
Investor Presentation
August 2023
inhibition provides broad oncology opportunity | Exscientia
BioAtla
Investor Presentation
August 2023
potential market opportunity in | BioAtla
AstraZeneca
Results
November 2024
solid | AstraZeneca
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights